Professor Neal Navani
Neal Navani qualified in Medicine from Cambridge University and UCL in 2000 with distinction and several University prizes. He trained in Respiratory Medicine at the Brompton and Hammersmith Hospitals before winning a Medical Research Council Fellowship in 2008 and completing his PhD at UCL in 2011. He has also completed an MSc in Clinical Trials and Biostatistics at the London School of Hygiene and Tropical Medicine.
Professor Navani is lead clinician for the lung cancer service at UCLH, and senior clinical lead of the National Lung Cancer Audit. He is on the steering committee of the British Thoracic Oncology Group, UK Lung Cancer Coalition and on the Thoracic Oncology committee of the American Thoracic Society.
Professor Navani currently holds >£2.5m of grant funding as chief investigator including a CRUK grant for the early diagnosis of lung cancer, a separate CRUK grant for developing novel methods for cancer data collection and NIHR funding for studies on predicting lung cancer prognosis with artificial intelligence and early detection of lung cancer in never smokers. He is an author of current NICE guidelines on lung cancer and bronchoscopy and co-chair of the BTS guideline on nodule management as well as a US guideline on peripheral bronchoscopy. He has over 150 peer-reviewed publications. In 2020, Dr Navani won a prestigious MRC / NIHR fellowship to research predictors of cancer in lung nodules and was appointed to Professor of Respiratory Medicine at UCL in 2024.
Professor Navani is lead clinician for the lung cancer service at UCLH, and senior clinical lead of the National Lung Cancer Audit. He is on the steering committee of the British Thoracic Oncology Group, UK Lung Cancer Coalition and on the Thoracic Oncology committee of the American Thoracic Society.
Professor Navani currently holds >£2.5m of grant funding as chief investigator including a CRUK grant for the early diagnosis of lung cancer, a separate CRUK grant for developing novel methods for cancer data collection and NIHR funding for studies on predicting lung cancer prognosis with artificial intelligence and early detection of lung cancer in never smokers. He is an author of current NICE guidelines on lung cancer and bronchoscopy and co-chair of the BTS guideline on nodule management as well as a US guideline on peripheral bronchoscopy. He has over 150 peer-reviewed publications. In 2020, Dr Navani won a prestigious MRC / NIHR fellowship to research predictors of cancer in lung nodules and was appointed to Professor of Respiratory Medicine at UCL in 2024.